Kentaro Minagawa

6PUBLICATIONS
11CO-AUTHORS
Medical mycologyHaematological tumoursTransplantation immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 27, 2026
Analyzing Real-World Infection Risk in Multiple Myeloma Patients Receiving Teclistamab.

Paddy Ssentongo, Emma G Guare, Chen Song

|Jun 19, 2025
Prior status of graft-versus-host disease affects donor lymphocyte infusion outcomes in patients with relapsed haematological malignancies after allogeneic stem cell transplantation.

Claudia Mae Velasco, Yoshitaka Inoue, Joseph Cioccio

|Dec 17, 2022
Donor HLA mismatch promotes full donor T-cell chimerism in the allogeneic stem cell transplant with reduced-intensity conditioning and post-transplant cyclophosphamide GVHD prophylaxis.

Joseph Cioccio, Kevin Rakszawski, Hong Zheng

|Sep 12, 2022
Non-myeloablative allogeneic stem cell transplant with fludarabine and reduced dose cyclophosphamide in acute myeloid leukemia for older adults with comorbidities.

Christopher J Pizzola, Joseph Cioccio, Kevin L Rakszawski

|Jul 29, 2021
Improved outcome in AML relapse after allogeneic transplant with high-intensity chemotherapy followed by 2nd allogeneic stem cell transplant or donor lymphocyte infusion.

Neal Shah, Kevin Rakszawski, Myles Nickolich

|Jul 21, 2021
Phase II clinical trial of one dose of post-transplant cyclophosphamide for graft versus host disease prevention following myeloablative, peripheral blood stem cell, matched-unrelated donor transplantation.

Omer Jamy, Raquel Innis-Shelton, Susan Bal

Pageof 1

Frequent Collaborators

2 joint publications

Seema Naik

2 joint publications

Yoshitaka Inoue

1 joint publications

Omer Jamy

1 joint publications

Luciano Costa